Cargando…
Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family
Nature is always the best inspiration for basic research. A family with severe thrombosis and antithrombin deficiency, the strongest anticoagulant, carried a new mutation affecting the translation-start codon of SERPINC1, the gene encoding antithrombin. Expression of this variant in a eukaryotic cel...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145704/ https://www.ncbi.nlm.nih.gov/pubmed/30237862 http://dx.doi.org/10.18632/oncotarget.26059 |
_version_ | 1783356295805403136 |
---|---|
author | Navarro-Fernández, José Eugenia de la Morena-Barrio, María Martínez-Alonso, Emma Dybedal, Ingunn Toderici, Mara Bohdan, Nataliya Miñano, Antonia Heimdal, Ketil Abildgaard, Ulrich Martínez-Menárguez, José Ángel Corral, Javier Vicente, Vicente |
author_facet | Navarro-Fernández, José Eugenia de la Morena-Barrio, María Martínez-Alonso, Emma Dybedal, Ingunn Toderici, Mara Bohdan, Nataliya Miñano, Antonia Heimdal, Ketil Abildgaard, Ulrich Martínez-Menárguez, José Ángel Corral, Javier Vicente, Vicente |
author_sort | Navarro-Fernández, José |
collection | PubMed |
description | Nature is always the best inspiration for basic research. A family with severe thrombosis and antithrombin deficiency, the strongest anticoagulant, carried a new mutation affecting the translation-start codon of SERPINC1, the gene encoding antithrombin. Expression of this variant in a eukaryotic cell system produced three different antithrombins. Two downstream methionines were used as alternative initiation codons, generating highly expressed small aglycosylated antithrombins with cytoplasmic localization. Wild-type antithrombin was generated by the use of the mutated AUU as initiation codon. Actually, any codon except for the three stop codons might be used to initiate translation in this strong Kozak context. We show unexpected consequences of natural mutations affecting translation-start codons. Downstream alternative initiation AUG codons may be used when the start codon is mutated, generating smaller molecules with potential different cell localization, biochemical features and unexplored consequences. Additionally, our data further support the use of other codons apart from AUG for initiation of translation in eukaryotes. |
format | Online Article Text |
id | pubmed-6145704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-61457042018-09-20 Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family Navarro-Fernández, José Eugenia de la Morena-Barrio, María Martínez-Alonso, Emma Dybedal, Ingunn Toderici, Mara Bohdan, Nataliya Miñano, Antonia Heimdal, Ketil Abildgaard, Ulrich Martínez-Menárguez, José Ángel Corral, Javier Vicente, Vicente Oncotarget Research Paper Nature is always the best inspiration for basic research. A family with severe thrombosis and antithrombin deficiency, the strongest anticoagulant, carried a new mutation affecting the translation-start codon of SERPINC1, the gene encoding antithrombin. Expression of this variant in a eukaryotic cell system produced three different antithrombins. Two downstream methionines were used as alternative initiation codons, generating highly expressed small aglycosylated antithrombins with cytoplasmic localization. Wild-type antithrombin was generated by the use of the mutated AUU as initiation codon. Actually, any codon except for the three stop codons might be used to initiate translation in this strong Kozak context. We show unexpected consequences of natural mutations affecting translation-start codons. Downstream alternative initiation AUG codons may be used when the start codon is mutated, generating smaller molecules with potential different cell localization, biochemical features and unexplored consequences. Additionally, our data further support the use of other codons apart from AUG for initiation of translation in eukaryotes. Impact Journals LLC 2018-09-04 /pmc/articles/PMC6145704/ /pubmed/30237862 http://dx.doi.org/10.18632/oncotarget.26059 Text en Copyright: © 2018 Navarro-Fernández et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Navarro-Fernández, José Eugenia de la Morena-Barrio, María Martínez-Alonso, Emma Dybedal, Ingunn Toderici, Mara Bohdan, Nataliya Miñano, Antonia Heimdal, Ketil Abildgaard, Ulrich Martínez-Menárguez, José Ángel Corral, Javier Vicente, Vicente Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family |
title | Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family |
title_full | Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family |
title_fullStr | Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family |
title_full_unstemmed | Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family |
title_short | Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family |
title_sort | biochemical and cellular consequences of the antithrombin p.met1? mutation identified in a severe thrombophilic family |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145704/ https://www.ncbi.nlm.nih.gov/pubmed/30237862 http://dx.doi.org/10.18632/oncotarget.26059 |
work_keys_str_mv | AT navarrofernandezjose biochemicalandcellularconsequencesoftheantithrombinpmet1mutationidentifiedinaseverethrombophilicfamily AT eugeniadelamorenabarriomaria biochemicalandcellularconsequencesoftheantithrombinpmet1mutationidentifiedinaseverethrombophilicfamily AT martinezalonsoemma biochemicalandcellularconsequencesoftheantithrombinpmet1mutationidentifiedinaseverethrombophilicfamily AT dybedalingunn biochemicalandcellularconsequencesoftheantithrombinpmet1mutationidentifiedinaseverethrombophilicfamily AT todericimara biochemicalandcellularconsequencesoftheantithrombinpmet1mutationidentifiedinaseverethrombophilicfamily AT bohdannataliya biochemicalandcellularconsequencesoftheantithrombinpmet1mutationidentifiedinaseverethrombophilicfamily AT minanoantonia biochemicalandcellularconsequencesoftheantithrombinpmet1mutationidentifiedinaseverethrombophilicfamily AT heimdalketil biochemicalandcellularconsequencesoftheantithrombinpmet1mutationidentifiedinaseverethrombophilicfamily AT abildgaardulrich biochemicalandcellularconsequencesoftheantithrombinpmet1mutationidentifiedinaseverethrombophilicfamily AT martinezmenarguezjoseangel biochemicalandcellularconsequencesoftheantithrombinpmet1mutationidentifiedinaseverethrombophilicfamily AT corraljavier biochemicalandcellularconsequencesoftheantithrombinpmet1mutationidentifiedinaseverethrombophilicfamily AT vicentevicente biochemicalandcellularconsequencesoftheantithrombinpmet1mutationidentifiedinaseverethrombophilicfamily |